Find Raphisiderite manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Blood stone, Iron ore, 1317-60-8, Iron oxides, Iron(3+);oxygen(2-), Iron(iii)oxide
Molecular Formula
Fe2O3
Molecular Weight
159.69  g/mol
InChI Key
LIKBJVNGSGBSGK-UHFFFAOYSA-N
FDA UNII
1K09F3G675

Raphisiderite
1 2D Structure

Raphisiderite

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
iron(3+);oxygen(2-)
2.1.2 InChI
InChI=1S/2Fe.3O/q2*+3;3*-2
2.1.3 InChI Key
LIKBJVNGSGBSGK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
[O-2].[O-2].[O-2].[Fe+3].[Fe+3]
2.2 Other Identifiers
2.2.1 UNII
1K09F3G675
2.3 Synonyms
2.3.1 MeSH Synonyms

1. C.i. 77491

2. Colcothar

3. Ferric Oxide

4. Ferric Oxide Hydrate

5. Ferric Oxide Monohydrate

6. Ferric Oxide Red

7. Gamma-ferric Oxide

8. Iron Oxide

9. Lepidocrocite

10. Maghemite

11. Red Iron Oxide

12. Spio

13. Supraparamagnetic Iron Oxide

2.3.2 Depositor-Supplied Synonyms

1. Blood Stone

2. Iron Ore

3. 1317-60-8

4. Iron Oxides

5. Iron(3+);oxygen(2-)

6. Iron(iii)oxide

7. Raphisiderite

8. Oligist

9. Specularite

10. Haematite

11. Miox

12. Iron, Specular

13. Red Iron Ore

14. Hematite (fe2o3)

15. Ccris 4377

16. Iron Oxide, Synthetic

17. Hsdb 2964

18. Einecs 215-275-4

19. Haematitum

20. Zheshi

21. Ocherum Rubrum

22. Mapico Red

23. Dai Zhe Hi

24. Hematite [inci]

25. Haematitum [chp]

26. Cosmetic Red Oxide

27. Ferric Oxide [ii]

28. Ferric Oxide [mi]

29. Ec 215-275-4

30. Iron Oxides [inci]

31. Ferric Oxide [iarc]

32. Iron Oxides [vandf]

33. Dai Country Red Stone

34. Ferric Oxide [vandf]

35. Ferric Oxide Red 30

36. Ferric Oxide Red-brown

37. Iron(iii) Oxide (fe2o3)

38. Ferric Oxide Red [ii]

39. Iron Oxide (e172)

40. Ins No.172(ii)

41. Iron Oxide Reddish-brown

42. E 172 Red

43. Ins-172(ii)

44. Ferric Oxide,red [vandf]

45. Ci 77491 [inci]

46. Red Iron Oxide R 1599d

47. Iron(iii) Oxide, Red (hematite)

48. Ferric Oxide Red 30 [ii]

49. E-172(ii)

50. Iron(iii) Oxide (e 172)

51. Akos025296075

52. Ferric Oxide Red [green Book]

53. Ferric Oxide (anhydrous) [nf]

54. Iron Oxide, Red (172(ii))

55. Ci Pigment Red 101 And 102

56. Haematite, Underground Mining With Exposure To Radon [haematite And Ferric Oxide]

57. Calamine Component Ferric Oxide Red

58. Ft-0627296

59. Ferric Oxide Red Component Of Calamine

60. Ci (1975) No. 77491

61. Q103223

62. Q419170

63. Haematite, Underground Mining With Exposure To Radon

64. 12002-17-4

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 159.69 g/mol
Molecular Formula Fe2O3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass159.854615 g/mol
Monoisotopic Mass159.854615 g/mol
Topological Polar Surface Area3 Ų
Heavy Atom Count5
Formal Charge0
Complexity0
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Pharmacology and Biochemistry
4.1 Absorption, Distribution and Excretion

... Proportion ... introduced into lungs of experimental animals remained within lungs of Tracheo-bronchial lymph nodes throughout their remaining life-span. Particles appear to penetrate walls of alveoli & respiratory bronchioles and remain in connective tissues of lung within macrophages which form clusters of various sizes.

IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V1 32 (1972)


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty